|
Akums Drugs & Pharmaceuticals Ltd.
|
Nine Months RESULTS
|
|
|
You can view the
Nine Months Results
for the last 5 years.
|
Market Cap. (Rs.)
|
7467.56 Cr.
|
P/BV
|
2.32
|
Book Value (Rs.)
|
204.41
|
|
52 Week High/Low (Rs.)
|
623/405
|
FV/ML
|
2/1
|
P/E(X)
|
22.08
|
|
Bookclosure
|
|
EPS (Rs.)
|
21.49
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Net Sales/Income from operations | 3201.15 | 3062.61 |
| Total Income From Operations | 3201.15 | 3062.61 |
| | | |
| EXPENDITURE | | |
| Consumption of Raw Materials | 1711.78 | 1629.76 |
| Purchase of Traded Goods | 138.07 | 161.98 |
| Increase/Decrease in Stocks | 3.21 | 2.60 |
| Employees Cost | 554.79 | 531.92 |
| Depreciation | 114.43 | 113.45 |
| Other Expenses | 423.00 | 365.77 |
| Total Expenses | 2945.28 | 2805.49 |
| | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 255.87 | 257.12 |
| Other Income | 93.42 | 34.58 |
| P/L Before Interest, Excpt. Items & Tax | 349.29 | 291.70 |
| Interest | 70.18 | 30.06 |
| P/L Before Exceptional Items & Tax | 279.11 | 261.64 |
| Exceptional Items | -18.23 | 8.48 |
| P/L Before Tax | 260.89 | 270.12 |
| Tax | 85.83 | 75.95 |
| P/L After Tax from Ordinary Activities | 175.06 | 194.17 |
| Net Profit/Loss For the Period | 175.06 | 194.17 |
| Net P/L After Minority Interest & Share Of Associates | 175.06 | 194.17 |
| | | |
| Equity Share Capital | 30.62 | 30.62 |
| EPS Before Extra Ordinary * | | |
| Basic EPS (Rs.) | 11.14 | 12.68 |
| Diluted EPS (Rs.) | 11.14 | 12.68 |
| EPS After Extra Ordinary * | | |
| Basic EPS (Rs.) | 11.14 | 12.68 |
| Diluted EPS (Rs.) | 11.14 | 12.68 |
| | | |
| PBITOE Margin (%) | 7.99 | 8.39 |
| PBTE Margin (%) | 8.71 | 8.54 |
| PBT Margin (%) | 8.14 | 8.81 |
| PAT Margin (%) | 5.46 | 6.34 |
| PAT After MI And SOA Margin (%) | 5.46 | 6.34 |
